29-10-2026 16:39 via Drugs.com - News for Health Professionals

ESMO: PFS, OS Extended With Divarasib in KRAS G12C-Mutated Advanced NSCLC

THURSDAY, Oct. 29, 2026-- Divarasib leads to significantly longer progression-free and overall survival than control treatment for patients with previously treated KRAS G12C-mutated advanced or metastatic non-small cell lung cancer (NSCLC)...
Read more »

Pharmaceutical news



Patients With Psoriasis Have Increased Risks for Cataracts, Cataract Surgery
Surgical Recurrence Less Frequent With Laparoscopic Surgery for Crohn Disease
Infectious Diseases Society of America, Oct. 21-24
Hypofractionated Postmastectomy RT Noninferior to Conventional PMRT
High-Volume Injections Not Beneficial in Midportion Achilles Tendinopathy
Childhood Measles Vaccination Rates Down Globally
American Society of Anesthesiologists, Oct. 16 to 20
New Swab Test Could Spare Some Women A Painful Biopsy For Endometrial Cancer
Omega-3s Might Improve Survival In Advanced Cancer, Trial Finds
Heated Tobacco: A New Trend That Is Raising Heart Health Concerns
Want to Lose Weight? Why Mixing Cardio And Strength Training Beats Any Single Workout
One-Third Of Young Adults Use AI Chatbots To Seek One Type Of Illicit Info
Public Awareness Of Alcohol's Cancer Risk Has Rebounded, Poll Reports
Living Alone Riskier For Young And Middle-Aged Adults Than Seniors, Study Indicates
Desktop versie